Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials

GM Felker, V Hasselblad, AF Hernandez… - American heart …, 2009 - Elsevier
BACKGROUND: Measurement of circulating natriuretic peptides has been shown to play an
important role in diagnosis and prognosis in patients with chronic heart failure. Whether …

[HTML][HTML] The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use

JL Januzzi Jr - Archives of cardiovascular diseases, 2012 - Elsevier
The care of patients with heart failure can be challenging, with few objective tools available
to assist in therapy decision-making. Natriuretic peptides are powerfully prognostic …

Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association

SL Chow, AS Maisel, I Anand, B Bozkurt, RA De Boer… - Circulation, 2017 - Am Heart Assoc
Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

[HTML][HTML] Biomarkers in routine heart failure clinical care

SK Nadar, MM Shaikh - Cardiac failure review, 2019 - ncbi.nlm.nih.gov
Heart failure is a clinical condition with complex pathophysiology that involves many
different processes. Diagnosis is often difficult in patients presenting for the first time with …

Rationale and design of the GUIDE-IT study: guiding evidence based therapy using biomarker intensified treatment in heart failure

GM Felker, T Ahmad, KJ Anstrom, KF Adams… - JACC: Heart Failure, 2014 - jacc.org
Abstract Objectives: The GUIDE-IT (Guiding Evidence Based Therapy Using Biomarker
Intensified Treatment in Heart Failure) study is designed to determine the safety, efficacy …

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure

R Latini, S Masson, M Wong, S Barlera… - The American journal of …, 2006 - Elsevier
PURPOSE: B-type natriuretic peptide is one of the most sensitive and specific biohumoral
markers of heart failure. We hypothesized that B-type natriuretic peptide changes during …

Natriuretic peptides in the diagnosis and management of heart failure

GM Felker, JW Petersen, DB Mark - Cmaj, 2006 - Can Med Assoc
The natriuretic peptides are a family of related hormones that play a crucial role in
cardiovascular homeostasis. They have recently emerged as potentially important clinical …

Natriuretic peptides in heart failure: should therapy be guided by BNP levels?

M O'donoghue, E Braunwald - Nature Reviews Cardiology, 2010 - nature.com
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for
natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP …

Effect of natriuretic peptide–guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a …

GM Felker, KJ Anstrom, KF Adams, JA Ezekowitz… - Jama, 2017 - jamanetwork.com
Importance The natriuretic peptides are biochemical markers of heart failure (HF) severity
and predictors of adverse outcomes. Smaller studies have evaluated adjusting HF therapy …

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management

JL Januzzi, R Troughton - Circulation, 2013 - Am Heart Assoc
Januzzi and Troughton Usefulness of NP-Guided Therapy 501 clinician judgment.
Furthermore, to achieve goals of therapy as outlined in guidelines, frequent office visits for …